NCT02647034

Brief Summary

This study investigated clinical parameters, laboratory data, imaging studies to evaluate patients with suspected pulmonary hypertension.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2009

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2009

Completed
6.5 years until next milestone

First Submitted

Initial submission to the registry

December 29, 2015

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 6, 2016

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

January 6, 2016

Status Verified

January 1, 2016

Enrollment Period

9.4 years

First QC Date

December 29, 2015

Last Update Submit

January 4, 2016

Conditions

Dyspnea

Outcome Measures

Primary Outcomes (1)

  • All-cause mortality

    an average of 1 year

Study Arms (2)

pulmonary hypertension

The two groups were defined by catheterization result. (no intervention)

Other: no intervention

non-pulmonary hypertension

The two groups were defined by catheterization result. (no intervention)

Other: no intervention

Interventions

no interventionOTHER

no intervention

non-pulmonary hypertensionpulmonary hypertension

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients suspicious for pulmonary hypertension

You may qualify if:

  • patients suspicious for pulmonary hypertension.

You may not qualify if:

  • pregnant, lactating, CAD history

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital and National Taiwan University College of Medicine

Taipei, 100, Taiwan

RECRUITING

MeSH Terms

Conditions

Dyspnea

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Mei-Fang Cheng, M.D.

    National Taiwan University Hospital and National Taiwan University College of Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mei-Fang Cheng, M.D.

CONTACT

886-2-23123456meifang@ntuh.gov.tw

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 29, 2015

First Posted

January 6, 2016

Study Start

July 1, 2009

Primary Completion

December 1, 2018

Study Completion

December 1, 2018

Last Updated

January 6, 2016

Record last verified: 2016-01

Locations

TW(1)